ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 393

$551K Total Retail Price of All Prescriptions

Rank: 50 out of 393

320 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 4,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 359 186 S3 1 5
SIMVASTATIN 250 157 2 1
AMLODIPINE BESYLATE 215 141 3 4
LISINOPRIL 198 88 4 2
METFORMIN HCL 192 106 5 7
LOSARTAN POTASSIUM 179 127 6 12
TRAMADOL HCL 159 103 7 30
CRESTOR 159 118 7 52
ZOLPIDEM TARTRATE 153 114 9 11
LEVOTHYROXINE SODIUM 148 101 10 3
OMEPRAZOLE 145 100 11 6
GABAPENTIN 120 70 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 74 13 24
TAMSULOSIN HCL 101 38 13 25
LIDODERM 99 96 15 116
MELOXICAM 93 67 16 58
ATORVASTATIN CALCIUM 79 61 17 19
LYRICA 71 61 18 119
ATENOLOL 67 53 19 13
METFORMIN HCL ER 64 41 20 63
POTASSIUM CHLORIDE 64 42 20 20
METOPROLOL TARTRATE 64 37 20 9
HYDROCHLOROTHIAZIDE 63 41 23 10
RANITIDINE HCL 61 37 24 29
CARVEDILOL 58 17 25 21
SPIRIVA 57 27 26 41
CIPROFLOXACIN HCL 57 45 26 57
CLOPIDOGREL 54 42 28 33
FAMOTIDINE 53 25 29 70
WARFARIN SODIUM 53 43 29 17
FUROSEMIDE 53 26 29 8
LOVAZA 51 24 32 114
NAMENDA 51 51 32 59
PANTOPRAZOLE SODIUM 50 23 34 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.